2020 Bionow Oncology Conference

2020 Bionow Oncology Conference

Digital Event
Wednesday 4th - Thursday 5th November 2020


The prevention of cancer and development of more effective strategies to detect precursors and early-stage cancers, when treatment may be most effective, remain critical societal goals.

The 2020 Bionow Oncology Conference will present the problems that we face with prevention and early diagnosis and discuss the latest advances to address these challenges and translate the science into better care for the cancer patient. In addition to leading experts we will also hear about this challenge from the patient’s perspective.

Cancer is always a complex question and there are no simple answers which is why it’s important to hear from those at the cutting edge of developments.

To promote careers & skills development within this critical industry, Bionow are enabling students from across the North of England to attend this years' event who will be able to engage with delegates from Sygnature Discovery, QIAGEN, Early Diagnostics Institute, Cancer Reserach UK, StreamBio, Zilico, The Clatterbridge Cancer Centre, Medicines Discovery Catapult, North West Cancer Research, Seda Pharmaceutical Development Services, Lonza Group, Crystec Pharma, Agility Life Sciences, Aptus Clinical, AS-Tec Chemicals Ltd, LGC, Histologix, Colibri Scientific, SRG, Yourgene Health, University of Manchester, Marks & Clerk, University of Bradford, Manchester Biogel, World Courier, LightOx, BPE Design & Support, High Force Research, Biocair, Onyx Health, Newcastle University, Xenogesis, University of Leeds, Alderley Park, Apconix, Quay Pharma, QV Bioelectronics, Apis Assay Technologies, Biorelate, Potter Clarkson, Alderley Park, Cell & Gene Therapy Catapult, Biofortuna, University of Huddersfield, Scientific Research Consultant, Alderley Analytical, HGF, Choice Telemed, University of Liverpool, Maucher Jenkins, GeneFirst Limited, Imagen Therapeutics, Illumina, Teeside University, BLD Pharmatech GmbH, LJMU, Lancaster University, Iksuda Therapeutics, Arcinova, TwinStrand Biosciences and many more to follow......

Conference Agenda

  • Virtual Reception Area Opens

  • Conference Welcome

    Geoff Davison, CEO, Bionow

  • Keynote Speaker

    Allan Jordan, Director - Oncology Drug Discovery, Sygnature Discovery

  • Cancer Diagnosis

    Chair: Jonathan Perkins, Associate Director Personalised Healthcare, QIAGEN
    Alexis Webb, Research Programme Manager – Early Detection, Cancer Research UK
    Andy Chaloner, CEO, Stream Bio
    Sameer Kothari, Chief Executive Director, Zilico
    ​Will Dracup, CEO, Early Diagnostics Institute

  • Virtual Coffee, Networking and Pre-booked Partnering Meetings

  • Patient Perspective

    Emily Lam, Public & Patient Involvement, The Clatterbridge Cancer Centre

  • Supporting Drug Discovery

    Chair: Peter Simpson, Chief Scientific Officer, Medicines Discovery Catapult
    Richard Weaver, Senior Vice President - Pre-Clinical Development, Sygnature Discovery
    Robert Falconer, Professor of Medicinal Chemistry and Deputy Director Institute of Cancer Therapeutics, Bradford University
    George Orphanides, Oncology Project Leader, Alderley Park

  • Virtual Coffee, Networking and Pre-booked Partnering Meetings

  • Supporting Pre-Clinical Development

    Chair: Jane Kendrew, Director of Translational Oncology, Sygnature Discovery
    Kim Rockley, Research Scientist, ApconiX
    Juliana Maynard, Lead Scientist, Medicines Discovery Catapult
    Caroline Phillips, Head of Oncology, Redx Pharma

  • Biotech & Beers Networking

  • Virtual Reception Area Open

  • Conference Welcome

    Geoff Davison, CEO, Bionow

  • Charity Perspective

    Alastair Richards, CEO, North West Cancer Research

  • Pharmaceutical Development

    Chair: Paul Stott, CEO, Seda Pharmaceutical Development Services
    Mike Frodsham, Chief Technical Officer, Quay Pharma
    Claire Patterson, Senior Principal Scientist, Seda Pharmaceutical Development Services
    Alyn McNaughton, Technical Director, Lonza Group
    Lyn Daintree, Development Director, Crystec Pharma

  • Virtual Coffee, Networking and Pre-booked Partnering Meetings

  • Cancer Cell Therapies

    Iain Armstrong, Partner, HGF 

  • The Impact of Covid Panel Session

    Chair: Claire Thompson, CEO, Agility Health
    Panel Members
    Steve McConchie, CEO, Aptus Clinical
    David Howat, Director of Medtech & Therapeutic Development, Stream Bio
    Allan Jordan, Director - Oncology Drug Discovery, Sygnature Discovery
    Ajay Mistry, CEO, Oppilotech



Registration will open shortly. For any further queries please contact info@bionow.co.uk

Showcase Companies






Company Showcase Packages

Each Company Showcase Package will consist of:- 

  • 1 x Delegate Pass
  • Pre-recorded Company Showcase (3 minutes in length)
  • Showcase uploaded to Event Delegate Area Pre-conference and available Post-conference
  • News Article promoting the Conference and Company showcases with link to pre-recorded material to be circulated to the network and Bionow website / newsletter
  • Social Media Content as a Showcase Company in the run up to the Event
  • Logo on Event page on Bionow website

Please click HERE to view the Company Showcase Guidelines